Abstract
Absorption, excretion and metabolism of a new ampicillin derivative, phthalidyl D-α-aminobenzylpenicillinate hydrochloride (PC-183), were studied. In comparison withampicillin, PC-183 showed the following characteristics.1. Upon oral administration in rats and humans, PC-183 was hydrolyzed and produced much higher plasma le urinary excretion of ampicillin was greater for PC-183 in both species. Concentration in tissues and bile of the rat was also higher for PC-183 than for ampicillin. These facts demonstrate superior intestinal absorption for PC-183 as compared with ampicillin.2. The compound was easily hydrolyzed in the presence of rat tissue extracts, such as liver, kidney or small intestine. This hydrolysis was also catalyzed by blood plasma, the activity of which was highest in rats and mice, followed by humans anddogs in that order. The hydrolysis was so rapid that any attempt to detect intact PC-183 in blood, urine and tissues after oral administration to rats and humans was unsuccessful.3. The hydrolysis products were ampicillin and phthalaldehydic acid. The latter was further metabolized to α-hydroxy-o-toluic acid and excreted into urine exclusively in this form. The metabolic pathway was the same for mice, rats, dogs and humans.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
